Nutritional management of cancer treatment effects:
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Buch |
Sprache: | English |
Veröffentlicht: |
Berlin [u.a.]
Springer
2012
|
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | XVII, 301 S. Ill., graph. Darst. |
ISBN: | 9783642272325 3642272320 9783642272332 |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV040142615 | ||
003 | DE-604 | ||
005 | 20120614 | ||
007 | t | ||
008 | 120519s2012 gw ad|| |||| 00||| eng d | ||
015 | |a 11,N48 |2 dnb | ||
016 | 7 | |a 1017296758 |2 DE-101 | |
020 | |a 9783642272325 |c Gb. : ca. EUR 149.75 (DE) (freier Pr.), ca. EUR 154.00 (AT) (freier Pr.), ca. sfr 201.00 (freier Pr.) |9 978-3-642-27232-5 | ||
020 | |a 3642272320 |9 3-642-27232-0 | ||
020 | |a 9783642272332 |c EBook |9 978-3-642-27233-2 | ||
024 | 3 | |a 9783642272325 | |
028 | 5 | 2 | |a Best.-Nr.: 80073046 |
035 | |a (OCoLC)796231288 | ||
035 | |a (DE-599)DNB1017296758 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
044 | |a gw |c XA-DE-BE | ||
049 | |a DE-355 | ||
082 | 0 | |a 616.99406 |2 22/ger | |
084 | |a XH 3120 |0 (DE-625)152887:12926 |2 rvk | ||
084 | |a 610 |2 sdnb | ||
100 | 1 | |a Kumar, Nagi B. |e Verfasser |4 aut | |
245 | 1 | 0 | |a Nutritional management of cancer treatment effects |c Nagi B. Kumar |
264 | 1 | |a Berlin [u.a.] |b Springer |c 2012 | |
300 | |a XVII, 301 S. |b Ill., graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
650 | 0 | 7 | |a Verdauungskanal |0 (DE-588)4078786-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Sekundärkrankheit |0 (DE-588)4131705-1 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Therapie |0 (DE-588)4059798-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Diät |0 (DE-588)4012031-4 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Nebenwirkung |0 (DE-588)4317914-9 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Fehlernährung |0 (DE-588)4204332-3 |2 gnd |9 rswk-swf |
689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
689 | 0 | 1 | |a Sekundärkrankheit |0 (DE-588)4131705-1 |D s |
689 | 0 | 2 | |a Verdauungskanal |0 (DE-588)4078786-2 |D s |
689 | 0 | 3 | |a Therapie |0 (DE-588)4059798-2 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
689 | 1 | 1 | |a Nebenwirkung |0 (DE-588)4317914-9 |D s |
689 | 1 | 2 | |a Fehlernährung |0 (DE-588)4204332-3 |D s |
689 | 1 | 3 | |a Diät |0 (DE-588)4012031-4 |D s |
689 | 1 | |5 DE-604 | |
856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=024999517&sequence=000004&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-024999517 |
Datensatz im Suchindex
_version_ | 1804149111742529536 |
---|---|
adam_text | Titel: Nutritional management of cancer treatment effects
Autor: Kumar, Nagi B.
Jahr: 2012
1 Introduction................................................................................................ 1
References.................................................................................................... 5
2 Assessment of Malnutrition and Nutritional Therapy Approaches
in Cancer Patients....................................................................................... 7
2.1 Definition............................................................................................. 7
2.2 Prevalence of Malnutrition in Cancer Patients.................................... 8
2.3 Etiology of Malnutrition...................................................................... 8
2.3.1 Tumor-Related Etiology........................................................... 8
2.3.2 Treatment-Related Etiology...................................................... 10
2.4 Assessment of Malnutrition in Cancer Patients.................................. 10
2.4.1 Nutritional Screening................................................................ 11
2.4.2 Nutritional Assessment............................................................. 13
2.5 Nutrition Therapy................................................................................ 23
2.5.1 Estimation of Nutritional Needs............................................... 24
2.6 Route of Nutrition Intervention........................................................... 28
2.6.1 Oral Intake................................................................................ 28
2.6.2 Enteral Nutrition....................................................................... 29
2.6.3 Parenteral Nutrition.................................................................. 33
2.7 Reassessment and Follow-up Nutritional Care................................... 34
2.8 Patient and Family Communication/Education................................... 34
2.9 Communication with Interdisciplinary Team...................................... 34
2.10 Future Directions................................................................................. 35
References.................................................................................................... 36
3 Cancer Anorexia (CA)................................................................................ 43
3.1 Definition/Description......................................................................... 44
3.2 Prevalence............................................................................................ 45
3.3 Etiology and Potential Mechanisms.................................................... 46
Contents
3.3.1 Tumor- and Treatment-Related Etiology of Anorexia.............. 46
3.3.2 Perturbations of the Physiological Regulation
of Eating Behavior as Etiology of Anorexia............................. 46
3.3.3 Psychosocial Etiology of Anorexia.......................................... 48
3.4 Current Therapies for Cancer Anorexia.............................................. 49
3.4.1 Timing of Diagnosis and Intervention...................................... 50
3.4.2 Nutrition Supplementation....................................................... 51
3.4.3 Appetite Stimulants and Other Pharmacotherapies
to Treat Anorexia...................................................................... 51
3.4.4 Increase Lean Body Mass with Physical Activity.................... 53
3.5 Guidelines for Treatment..................................................................... 53
3.5.1 Nutrition Guidelines................................................................. 53
3.5.2 Pharmacotherapy...................................................................... 56
3.5.3 Speech Therapist...................................................................... 56
3.5.4 Physical Activity....................................................................... 56
3.5.5 Follow-up.................................................................................. 59
3.6 Future Directions................................................................................. 59
References.................................................................................................... 61
Cancer Cachexia (CC)............................................................................... 65
4.1 Definition............................................................................................. 66
4.2 Prevalence............................................................................................ 66
4.3 Etiology of Cancer Cachexia............................................................... 66
4.3.1 Potential Molecular Mechanisms of CC................................... 67
4.4 Current Therapies for CC.................................................................... 69
4.4.1 Nutritional Approaches............................................................ 69
4.4.2 Appetite Stimulants.................................................................. 72
4.4.3 Physical Activity....................................................................... 73
4.5 Guidelines for Treatment..................................................................... 73
4.5.1 Nutrition Guidelines................................................................. 74
4.5.2 Pharmacotherapy...................................................................... 76
4.5.3 Physical Activity....................................................................... 76
4.5.4 Markers and Instruments for Patient Monitoring
and Assessment of Response to Treatment by the
Interdisciplinary Medical Team................................................ 76
4.5.5 Follow-up.................................................................................. 79
4.6 Future Directions................................................................................. 79
References.................................................................................................... 80
Oral Mucositis............................................................................................. 85
5.1 Definition............................................................................................. 86
5.2 Prevalence............................................................................................ 87
5.3 Etiology............................................................................................... 88
5.3.1 Patient- and Treatment-Related Etiology of Mucositis............ 88
5.3.2 Biologic Development of Mucositis......................................... 90
Contents xiii
5.4 Current Therapies for Mucositis.......................................................... 90
5.4.1 Assessment and Early Identification of Oral Mucositis........... 90
5.4.2 Treatment Approaches with Immunomodulators,
Amino Acids, and Vitamins..................................................... 91
5.4.3 Physical Approaches for the Prevention and Treatment
of Oral Mucositis...................................................................... 93
5.4.4 Treatment Approaches of Related Symptom Clusters
to Oral Mucositis...................................................................... 93
5.5 Guidelines for Assessment and Treatment of Oral Mucositis............. 94
5.5.1 Assessment of Mucositis.......................................................... 95
5.5.2 Dental Care Guidelines............................................................. 96
5.5.3 Pharmacotherapy...................................................................... 96
5.5.4 Nutrition Guidelines................................................................. 97
5.5.5 Physical Activity....................................................................... 99
5.5.6 Markers and Instruments for Patient Monitoring
and Assessment of Response to Treatment by the
Interdisciplinary Medical Team................................................ 99
5.5.7 Follow-up.................................................................................. 101
5.6 Future Directions................................................................................. 102
References.................................................................................................... 103
6 Nausea and Vomiting in Cancer................................................................ 107
6.1 Definition/Description......................................................................... 108
6.2 Prevalence............................................................................................ 109
6.3 Etiology/Common Causes................................................................... 109
6.3.1 Neurophysiology of Nausea and Vomiting............................... 110
6.3.2 Cytotoxic Chemotherapy and Radiation-Induced
Mechanisms.............................................................................. Ill
6.3.3 Tumor-Induced Nausea and Vomiting...................................... 112
6.3.4 Drugs Contributing to Nausea and Vomiting............................ 112
6.3.5 Psychological Etiology............................................................. 112
6.4 Current Treatment of Nausea and Vomiting........................................ 113
6.4.1 Pharmacological Approaches................................................... 114
6.4.2 Nonpharmacological Approaches............................................ 116
6.5 Guidelines for the Management of Nausea and Vomiting.................. 119
6.5.1 Assessment............................................................................... 119
6.5.2 Pharmacologic Interventions.................................................... 119
6.5.3 Nutrition Guidelines................................................................. 120
6.5.4 Markers and Instruments for Patient Monitoring
and Assessment of Response to Treatment by the
Interdisciplinary Medical Team................................................ 122
6.5.5 Dentist....................................................................................... 125
6.5.6 Follow-up.................................................................................. 125
6.6 Future Directions................................................................................. 125
References.................................................................................................... 127
xiv Contents
7 Cancer-Related Fatigue (CRF).................................................................. 131
7.1 Definition............................................................................................. 132
7.2 Prevalence............................................................................................ 132
7.3 Etiology of Fatigue in Cancer............................................................. 133
7.3.1 Physiological Factors................................................................ 135
7.3.2 Medications.............................................................................. 142
7.3.3 Psychological Factors............................................................... 142
7.3.4 Environmental Factors.............................................................. 144
7.4 Current Treatment Approaches........................................................... 144
7.4.1 Assessment of Etiology of Fatigue........................................... 145
7.4.2 Pharmacological Approaches/Treating Comorbidities............. 145
7.4.3 Nonpharmacological Approaches............................................ 147
7.5 Guidelines............................................................................................ 150
7.5.1 Comprehensive Assessment..................................................... 151
7.5.2 Pharmacological Interventions................................................. 152
7.5.3 Nonpharmacological Interventions........................................... 152
7.6 Future Directions................................................................................. 157
References.................................................................................................... 159
8 Treatment-Induced Enteritis (Radiation- or Combination
Therapy-Induced Enteropathies).............................................................. 171
8.1 Definition............................................................................................. 172
8.2 Prevalence............................................................................................ 173
8.3 Etiology............................................................................................... 173
8.4 Current Therapies for Treatment of Alimentary Tract Enteritis.......... 175
8.4.1 Screening and Comprehensive Evaluation............................... 176
8.4.2 Radiation Techniques............................................................... 176
8.4.3 Surgical Management............................................................... 177
8.4.4 Pharmaceutical Management.................................................... 178
8.4.5 Nutritional Management........................................................... 179
8.5 Guidelines for Treatment of Gastrointestinal Mucositis/Radiation
Enteritis............................................................................................... 180
8.5.1 Assessment and Medical/Surgical Management...................... 181
8.5.2 Nutritional Assessment and Therapy........................................ 182
8.5.3 Pharmacotherapy...................................................................... 184
8.5.4 Markers and Instruments for Patient Monitoring
and Assessment of Response to Treatment by the
Interdisciplinary Medical Team................................................ 185
8.5.5 Follow-up.................................................................................. 187
8.6 Future Directions................................................................................. 187
References.................................................................................................... 189
9 Neurocognitive Impairment (NI)............................................................... 193
9.1 Definition............................................................................................. 194
9.2 Prevalence............................................................................................ 195
Contents xv
9.3 Etiology............................................................................................... 196
9.3.1 Etiology of NI in All Cancers................................................... 196
9.3.2 Etiology of NI in Adult Cancers............................................... 196
9.3.3 Etiology of NI in Childhood Cancers and Adult
Survivors of Childhood Cancers............................................... 197
9.4 Current Interventions for the Treatments for
Chemotherapy-Induced Cognitive Impairment................................... 199
9.4.1 Treatment of Anemia................................................................ 199
9.4.2 Treatment of Fatigue.................................................................200
9.4.3 Cognitive Training (CT)...........................................................201
9.4.4 Timing of Intervention..............................................................204
9.5 Guidelines............................................................................................205
9.5.1 Neuropsycho-Oncology Referral..............................................205
9.5.2 Nutrition Screening, Assessment, and Therapy........................206
9.5.3 Physical Activity.......................................................................207
9.5.4 Markers and Instruments for Patient Monitoring
and Assessment of Response to Treatment by the
Interdisciplinary Medical Team................................................208
9.5.5 Follow-up..................................................................................211
9.6 Future Directions.................................................................................211
References....................................................................................................212
10 Dysfunction of the Bowel/Constipation....................................................221
10.1 Definition.............................................................................................222
10.2 Prevalence............................................................................................223
10.3 Etiology...............................................................................................224
10.3.1 Medications for Cancer Treatment.........................................224
10.3.2 Tumor or Tumor-Radiation-Induced Constipation.................227
10.3.3 Psychological Factors.............................................................227
10.4 Current Treatment for Cancer or Treatment-Induced Constipation.... 228
10.4.1 Assessment..............................................................................228
10.4.2 Pharmacological Interventions................................................ 229
10.4.3 Nonpharmacological Approaches...........................................233
10.5 Guidelines............................................................................................233
10.5.1 Comprehensive Assessment.................................................... 233
10.5.2 Pharmacotherapy.....................................................................234
10.5.3 Nonpharmacological Interventions.........................................235
10.5.4 Markers and Instruments for Patient Monitoring
and Assessment of Response to Treatment by the
Interdisciplinary Medical Team..............................................237
10.5.5 Follow-up................................................................................240
10.6 Future Directions.................................................................................240
References....................................................................................................242
xvi Contents
11 Dysphagia....................................................................................................245
11.1 Definition/Description.........................................................................246
11.2 Prevalence............................................................................................247
11.3 Etiology...............................................................................................248
11.3.1 Tumor Location-Related Effects............................................248
11.3.2 Chemotherapy-Related Effects...............................................250
11.3.3 Radiation and Chemoradiation Therapy-Related Effects.......250
11.4 Current Treatment Strategies for Dysphagia.......................................252
11.4.1 Screening and Initial Assessment...........................................252
11.4.2 Nutritional Interventions......................................................... 254
11.4.3 Physical Therapy.....................................................................255
11.4.4 Pharmacotherapies..................................................................256
11.5 Guidelines............................................................................................256
11.5.1 Nutrition Guidelines................................................................257
11.5.2 Speech Pathologist/Radiologist..............................................258
11.5.3 Nutrition Intervention.............................................................258
11.5.4 Dentist.....................................................................................261
11.5.5 Pharmacotherapy.....................................................................261
11.5.6 Physical Activity.....................................................................262
11.5.7 Markers and Instruments for Patient Monitoring
and Assessment of Response to Treatment by the
Interdisciplinary Medical Team..............................................262
11.5.8 Follow-up................................................................................265
11.6 Future Directions.................................................................................265
References....................................................................................................267
12 Alterations in Taste and Smell...................................................................271
12.1 Definition.............................................................................................272
12.2 Prevalence............................................................................................273
12.3 Etiology/Common Causes...................................................................274
12.3.1 Chemotherapy Induced...........................................................275
12.3.2 Radiation Therapy Induced.....................................................277
12.3.3 Other Causes of Taste and Smell Alterations in Cancer.........279
12.4 Current Treatment Strategies...............................................................279
12.4.1 Assessment..............................................................................280
12.4.2 Pharmacological......................................................................281
12.4.3 Nonpharmacological...............................................................282
12.5 Guidelines for Management................................................................283
12.5.1 Education of Patient and Family About These Symptoms.....283
12.5.2 Referral to Dentist...................................................................283
12.5.3 Treatment of Infections...........................................................284
12.5.4 Screening for Alterations in Taste and Smell..........................284
Contents xvii
12.5.5 Current Treatment...................................................................284
12.5.6 Other Causes Must Be Examined...........................................284
12.5.7 Nutrition Guidelines...............................................................285
12.5.8 Pharmacotherapy....................................................................287
12.5.9 Markers and Instruments for Patient Monitoring
and Assessment of Response to Treatment
by the Interdisciplinary Medical Team...................................287
12.5.10 Follow-up................................................................................289
12.6 Future Directions.................................................................................290
References....................................................................................................291
Index...................................................................................................................295
|
any_adam_object | 1 |
author | Kumar, Nagi B. |
author_facet | Kumar, Nagi B. |
author_role | aut |
author_sort | Kumar, Nagi B. |
author_variant | n b k nb nbk |
building | Verbundindex |
bvnumber | BV040142615 |
classification_rvk | XH 3120 |
ctrlnum | (OCoLC)796231288 (DE-599)DNB1017296758 |
dewey-full | 616.99406 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.99406 |
dewey-search | 616.99406 |
dewey-sort | 3616.99406 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02349nam a2200589 c 4500</leader><controlfield tag="001">BV040142615</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20120614 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">120519s2012 gw ad|| |||| 00||| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">11,N48</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1017296758</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783642272325</subfield><subfield code="c">Gb. : ca. EUR 149.75 (DE) (freier Pr.), ca. EUR 154.00 (AT) (freier Pr.), ca. sfr 201.00 (freier Pr.)</subfield><subfield code="9">978-3-642-27232-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3642272320</subfield><subfield code="9">3-642-27232-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783642272332</subfield><subfield code="c">EBook</subfield><subfield code="9">978-3-642-27233-2</subfield></datafield><datafield tag="024" ind1="3" ind2=" "><subfield code="a">9783642272325</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">Best.-Nr.: 80073046</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)796231288</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1017296758</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99406</subfield><subfield code="2">22/ger</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 3120</subfield><subfield code="0">(DE-625)152887:12926</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Kumar, Nagi B.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Nutritional management of cancer treatment effects</subfield><subfield code="c">Nagi B. Kumar</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin [u.a.]</subfield><subfield code="b">Springer</subfield><subfield code="c">2012</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XVII, 301 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Verdauungskanal</subfield><subfield code="0">(DE-588)4078786-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Sekundärkrankheit</subfield><subfield code="0">(DE-588)4131705-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Diät</subfield><subfield code="0">(DE-588)4012031-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Nebenwirkung</subfield><subfield code="0">(DE-588)4317914-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Fehlernährung</subfield><subfield code="0">(DE-588)4204332-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Sekundärkrankheit</subfield><subfield code="0">(DE-588)4131705-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Verdauungskanal</subfield><subfield code="0">(DE-588)4078786-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Nebenwirkung</subfield><subfield code="0">(DE-588)4317914-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Fehlernährung</subfield><subfield code="0">(DE-588)4204332-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="3"><subfield code="a">Diät</subfield><subfield code="0">(DE-588)4012031-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=024999517&sequence=000004&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-024999517</subfield></datafield></record></collection> |
id | DE-604.BV040142615 |
illustrated | Illustrated |
indexdate | 2024-07-10T00:17:50Z |
institution | BVB |
isbn | 9783642272325 3642272320 9783642272332 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-024999517 |
oclc_num | 796231288 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | XVII, 301 S. Ill., graph. Darst. |
publishDate | 2012 |
publishDateSearch | 2012 |
publishDateSort | 2012 |
publisher | Springer |
record_format | marc |
spelling | Kumar, Nagi B. Verfasser aut Nutritional management of cancer treatment effects Nagi B. Kumar Berlin [u.a.] Springer 2012 XVII, 301 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Verdauungskanal (DE-588)4078786-2 gnd rswk-swf Sekundärkrankheit (DE-588)4131705-1 gnd rswk-swf Therapie (DE-588)4059798-2 gnd rswk-swf Diät (DE-588)4012031-4 gnd rswk-swf Nebenwirkung (DE-588)4317914-9 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Fehlernährung (DE-588)4204332-3 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 s Sekundärkrankheit (DE-588)4131705-1 s Verdauungskanal (DE-588)4078786-2 s Therapie (DE-588)4059798-2 s DE-604 Nebenwirkung (DE-588)4317914-9 s Fehlernährung (DE-588)4204332-3 s Diät (DE-588)4012031-4 s HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=024999517&sequence=000004&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Kumar, Nagi B. Nutritional management of cancer treatment effects Verdauungskanal (DE-588)4078786-2 gnd Sekundärkrankheit (DE-588)4131705-1 gnd Therapie (DE-588)4059798-2 gnd Diät (DE-588)4012031-4 gnd Nebenwirkung (DE-588)4317914-9 gnd Krebs Medizin (DE-588)4073781-0 gnd Fehlernährung (DE-588)4204332-3 gnd |
subject_GND | (DE-588)4078786-2 (DE-588)4131705-1 (DE-588)4059798-2 (DE-588)4012031-4 (DE-588)4317914-9 (DE-588)4073781-0 (DE-588)4204332-3 |
title | Nutritional management of cancer treatment effects |
title_auth | Nutritional management of cancer treatment effects |
title_exact_search | Nutritional management of cancer treatment effects |
title_full | Nutritional management of cancer treatment effects Nagi B. Kumar |
title_fullStr | Nutritional management of cancer treatment effects Nagi B. Kumar |
title_full_unstemmed | Nutritional management of cancer treatment effects Nagi B. Kumar |
title_short | Nutritional management of cancer treatment effects |
title_sort | nutritional management of cancer treatment effects |
topic | Verdauungskanal (DE-588)4078786-2 gnd Sekundärkrankheit (DE-588)4131705-1 gnd Therapie (DE-588)4059798-2 gnd Diät (DE-588)4012031-4 gnd Nebenwirkung (DE-588)4317914-9 gnd Krebs Medizin (DE-588)4073781-0 gnd Fehlernährung (DE-588)4204332-3 gnd |
topic_facet | Verdauungskanal Sekundärkrankheit Therapie Diät Nebenwirkung Krebs Medizin Fehlernährung |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=024999517&sequence=000004&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
work_keys_str_mv | AT kumarnagib nutritionalmanagementofcancertreatmenteffects |